Company Filing History:
Years Active: 2024
Title: Innovations of Inventor Tong Zhang
Introduction
Tong Zhang is an accomplished inventor based in Lebanon, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric receptors for T cells. His work focuses on enhancing the capabilities of immune cells to combat diseases.
Latest Patents
Tong Zhang holds a patent for "Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing." This invention is directed to T cells and other cells that express chimeric NK-p30 receptors, known as chimeric NKp30 T cells. The patent outlines methods for making and using these chimeric NKp30 T cells, as well as their applications in reducing, ameliorating, or preventing diseases and disorders.
Career Highlights
Tong Zhang is affiliated with Dartmouth College, where he conducts research and collaborates with other scientists. His work has led to advancements in the understanding of immune responses and the potential for innovative therapies.
Collaborations
One of his notable collaborators is Charles L Sentman, with whom he has worked on various projects related to T cell engineering and immunotherapy.
Conclusion
Tong Zhang's contributions to the field of biotechnology through his innovative patent and research at Dartmouth College highlight the importance of advancements in immune cell therapies. His work continues to pave the way for new treatments in the medical field.